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Introduction
It is widely recognized that the increased production of oxygen-
derived radical species is a key event involved in cardiovascular
pathologies, including hypertension, cardiac hypertrophy and
heart failure [1–3]. Oxidative stress is also implicated in the meta-
bolic and functional alterations associated with ischaemia-reperfu-
sion (I/R) injury [4, 5]. The activation of enzymes such as xanthine
oxidase or the uncoupling of the mitochondrial electron transport
chain are believed to play an important role in reactive oxygen
species (ROS) production [6, 7]. Recent studies have suggested
NADPH oxidase as a major cardiovascular ROS source, whose
activity appears enhanced by several stimuli relevant to vascular
and heart disease, such as angiotensin II, norepinephrine and
TNF [8, 9]. NADPH oxidase is a multimeric enzyme that contains
a core membrane-bound flavocytochrome comprising a catalytic
NOX subunit and a lower molecular weight p22phox subunit. So far,
five NOX isoforms (NOX1–5) have been identified in different tissues
[10, 11]. NOX2 and NOX4, the main isoforms expressed in cardiac
cells [12–14], are subjected to a different biochemical regulation.
At variance with NOX4, NOX2 (or gp91phox) activation requires the
association of cytosolic regulatory subunits (p47phox, p67phox,
p40phox and Rac1) [8]. The increase in subunits expression and/or
the translocation of regulatory subunits (in particular p47phox)
from the cytosol to the membrane represent prerequisites for
NOX2 activation and ROS production [8, 15–17]. NADPH oxidase
activity and subunits expression are increased in experimental
models of pressure overload left ventricular hypertrophy [13, 16].
Recently, we found that the NADPH oxidase activity was increased
in the left and right ventricle of myocardium of patients with end-
stage heart failure, and that this increase was associated with
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Abstract
Oxidative stress is associated with several cardiovascular pathologies, including hypertension, cardiac hypertrophy and heart failure.
Although oxidative stress is also increased after ischaemia-reperfusion (I/R), little is known about the role and the activation mecha-
nisms, in cardiac myocytes under these conditions, of NADPH oxidase, a superoxide-producing enzyme. We found that rat cardiac muscle
cells (H9c2) subjected to an in vitro simulated ischaemia (substrate-free medium plus hypoxia) followed by ‘reperfusion’, displayed
increased reactive oxygen species (ROS) production attributable to a parallel increase of NADPH oxidase activity. Our investigation on
mechanisms responsible for NADPH oxidase activation showed a contribution of both the increase of NOX2 expression and p47phox
translocation to the membrane. We also found that the increase of NADPH oxidase activity was associated with higher levels of lipid per-
oxidation, the activation of redox-sensitive kinases, in particular ERK and JNK, and with cell death. Diphenyleneiodonium (DPI), a flavo-
protein inhibitor used as NADPH oxidase inhibitor, prevented I/R-induced ROS formation in treated cells, together with the related
lipoperoxidative damage, and JNK phosphorylation without affecting ERK activation, resulting in protection against cell death. Our
results provide evidence that NADPH oxidase is a key enzyme involved in I/R-induced oxidant generation and suggest it can be a 
possible target in cardioprotective strategies against I/R injury, a condition of great importance in human pathology.
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p47phox translocation [18]. Instead, no convincing evidence on the
role of cardiomyocyte NADPH oxidase in I/R has been reported.
ROS arising from the NADPH oxidase activity appear involved
in modulating redox-sensitive signalling pathways, such as mito-
gen-activated protein kinase (MAPK) [8]. They consist of three
major subfamilies: the extracellular signal-regulated kinase (ERK),
mainly implicated in cell survival and proliferation [19, 20], as well
as p38 and c-jun NH2-terminal kinase (JNK), both related to cell
death [21–23]. However, the exact role of the NADPH oxidase in
signal-transduction remains largely unknown.
In the present study, the I/R was simulated in H9c2 cardiomy-
oblasts, a cell line extensively used in cardiological research since
it shares most of the molecular and functional features of adult
cardiomyocytes [24].
The aims of our investigation were the following: (1) investigat-
ing the role played by NADPH oxidase in cardiac cells exposed 
to simulated ischaemia/‘reperfusion’; (2) assessing whether
NADPH oxidase-derived ROS are involved in the activation of
redox-sensitive signalling pathways; (3) describing the possible
role performed by members of the MAPK family in cell death; (4)
checking whether cardiomyocyte damage can be prevented by the
use of NADPH oxidase (and MAPK) inhibitor(s).
Materials and methods
Cell cultures
Embryonic rat cardiomyoblasts (line H9c2 (2–1), n 88092904) were pro-
vided from European Collection of Cell Cultures (ECACC, Salisbury, UK).
H9c2 cells were plated at a density of 5  105/ 100 mm plate and cultured
at 37C in 5% CO2 humidified atmosphere in Dulbecco’s Modified Eagles
Medium (DMEM, Sigma, Italy) supplemented with 10% heat-inactivated
foetal bovine serum (FBS), 1% L-glutamine, 1% streptomycin and 1%
penicillin. Cells were passaged regularly and sub-cultured to about
70–80% before experimental procedures.
Experimental protocol
Simulated ischaemia was obtained as previously reported [25] with minor
modifications. Briefly, H9c2 cells were cultured in a low volume of sub-
strate-free medium (serum-free, glucose-free and sodium pyruvate-free
DMEM, DME base, Sigma, Italy) into an anaerobic Plexiglas chamber
(Billups-Rothenberg Inc., CA, USA), saturated with 95% N2 and 5% CO2,
at 37C for 24 hrs. The volume of hypoxic medium used was the minimum
volume required to coat the cellular monolayer for the prevention of cellular
dehydration during the ischaemic period. Simulated ischaemia was 
followed by a simulated ‘reperfusion’ period during which the cells 
were exposed to normoxic fresh culture medium at 37C for 60 min. in 
the absence and in the presence of the following drugs: 10 M
diphenyleneiodonium chloride (DPI, Sigma, Italy), a flavoprotein inhibitor,
and 100 M apocynin (Sigma, Italy), both ones used as NADPH oxidase
inhibitors, 10 mM 4,5-dihydroxy-1,3-benzene-disulfonic acid (Tiron,
Sigma, Germany), a superoxide scavenger, 10 M rotenone (Sigma, Italy),
a mitochondrial oxidase complex I inhibitor, 100 M oxypurinol (Sigma,
Italy), a xanthine oxidase inhibitor, and 20 M SP600125 (Sigma, Italy), 
a selective JNK inhibitor compound. Since some of these compounds were
dissolved in dimethyl sulphoxide (DMSO), the same amount of the drugs
was added to control cells to evaluate their possible toxic effects (data not
shown).
Sample preparation and protein content 
measurement
At the end of ‘reperfusion’, cells were washed with ice-cold PBS, harvested
with a 0.25% Trypsin-EDTA solution, lysed in an ice-cold lysis buffer (10 mM
Tris HCl, pH 7.4 containing 150 mM NaCl, 2 mM EGTA, 2 mM DTT, 10 g/ml
leupeptin, 10 g/ml aprotinin, 1 mM PMSF and phosphatase inhibitor
cocktail) for 60 min. and sonicated three times on ice for an overall 15 sec.
time period. Then the samples were centrifuged at 3000 rpm at 4C, and
the supernatants were assayed for protein concentration by bicinchoninic
acid (BCA) protein assay (Pierce, Italy), superoxide production, lipid per-
oxidation and subjected to Western blotting. To evaluate NOX2 (gp91phox)
protein expression and p47phox translocation, membrane and cytosolic
fractions of the homogenates were separated by ultracentrifugation at
100,000 g for 60 min. at 4C, and used for immunoblotting. The ‘purity’
of membrane and cytosolic fractions were confirmed by marker enzyme
activities as previously described [26].
Measurement of intracellular ROS
Intracellular ROS content was measured by monitoring the oxidation of 
10 M 2, 7-dihydrodichlorofluorescein diacetate (H2DCF-DA, Invitrogen,
Italy), a cell permeable compound, to fluorescent dichlorofluorescein as
described previously [27]. Briefly, the cells, cultured in a 6-well plate, were
treated with 10 M H2DCF-DA 10 min. before the end of reperfusion. After
PBS washing, the cells were lysed in lysis buffer and immediately analysed
on Fluoroskan Ascent Fluorometer (Thermo Electron Corporation, Finland).
DCF fluorescence was expressed as arbitrary units (A U) and normalized to
the total protein content.
Superoxide production assay
Superoxide production was assessed by lucigenin-enhanced chemilumi-
nescence as described previously [18]. Experiments were performed on a
luminometer (Lumat LB 9507 EG&G Berthold) using 0.1 mg lysed cell 
protein/tube and a non-redox–cycling 5 M lucigenin concentration.
Superoxide generation was measured at room temperature in the absence
or in the presence of the substrates of either the NADPH oxidase (0.3 mM
NADPH), the mitochondrial oxidase complex I (5 mM succinate) or the
xanthine oxidase (1 mM xanthine), respectively. Further measurements
were taken after the addition of the oxidase inhibitors: diphenyleneiodo-
nium (10 M DPI), a flavoprotein inhibitor used as NADPH oxidase
inhibitor, rotenone (50 M), a mitochondrial oxidase complex I inhibitor or
oxypurinol (100 M), a xanthine oxidase inhibitor. A cell-permeable super-
oxide scavenger 4,5-dihydroxy-1,3-benzene-disulfonic acid (Tiron, 20 mM)
was also used. A buffer blank was subtracted from each reading.
Superoxide production was expressed as mean arbitrary light units per mg
protein per sec. over a 10-min. period.
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Lipid peroxidation assay
To assess the level of lipid peroxidation, malondialdehyde (MDA) content
was determined using a ‘Biooxytech LPO-586 Assay’ kit (Oxis International
Inc., Prodotti Gianni, Italy).
Western blotting
Equal protein amounts of lysed cell homogenate, membrane or cytosolic
proteins were separated on 12% SDS-PAGE and transferred to polyvinyli-
dene difluoride (PVDF) membranes. After blocking with 5% (w/v) BSA in
0.1% (v/v) PBS-Tween, the membranes were incubated overnight at 4C
with goat-anti-NOX2(gp91phox) (1:1000, sc-5827), and goat anti-p47phox
antibodies (1:1000, sc-7660) (Santa Cruz Biotechnology, Santa Cruz, CA,
USA). -actin, detected with mouse monoclonal antibody (1:1000, 
sc-32251), was used as a loading control and HL-60 cell lysate (sc-2209)
as a positive control for the detection of NOX2 (Santa Cruz Biotechnology).
MAPK activation was assessed by Western blotting using rabbit mon-
oclonal antibodies that specifically recognize the phosphorylated active
forms of these kinases (1:1000, #9938 Phospho- MAPK family kit, Cell
Signaling Technology, MA, USA). The results are expressed relative to their
total protein content, detected with rabbit polyclonal anti-JNK (1:1000, 
sc-571), anti-ERK (1:1000, sc-93) and anti-p-38 (1:1000, sc-535) antibodies
(Santa Cruz Biotechnology). Anti-goat (1:3000, sc- 2020) or anti-rabbit
(1:10000, sc- 2004) and anti-mouse (1:5000, sc- 2005) peroxidase-
conjugated antibodies were used (Santa Cruz Biotechnology).
Immunoreactive bands were detected by chemiluminescence Super
Signal West Dura solution (Pierce, Italy) and quantified by densitometry
analysis using a Chemi Doc system and Quantity One software (Bio-RAD
Laboratories, Italy).
Immunofluorescence analysis for NOX2 protein
expression and p47phox membrane translocation
For immunofluorescence staining, H9c2 cells were grown on coverslips
(VWR, Strasbourg, France) in 35-mm culture dishes (Barloworld Sci,
Milan, Italy). After I/R, cells were fixed with 3% (v/v) paraformald-
heyde/PBS for 20 min. at 4C, permeabilized with 0.1% (v/v) Triton-X-
100/TBS and blocked with PBS containing 1% BSA and 10% horse serum
for 60 min. The coverslips were incubated overnight at 4C with 1:50 goat-
anti-NOX2 (gp91phox) or goat-anti-p47phox antibodies dissolved in TBS
containing 3% BSA. After washing three times in 0.1% Triton-X-100/TBS
and once with 0.1% BSA in 0.1% Triton-X-100/TBS, a 1:400 fluorescein-
isothiocyanate (FITC)-conjugated anti-goat secondary antibody (green flu-
orescence, Fluka, Switzerland) was added for 60 min. After several wash-
es in 0.1% Triton-X-100/TBS the cell nuclei were stained with a propidium
iodide solution (Fluka, Switzerland). Coverslips were aspirated dry, sealed
with glass slides in Gel Mount (Sigma, Italy) and observed by a TCS-SP5
confocal microscopy (Leica Microsystems, Germany), performed with a
488 nm argon ion laser line for FITC excitation.
Cell death assessment
Cell viability was determined by Trypan blue (TB) dye uptake. Cells were
gently harvested and mixed with 0.4% TB solution (Sigma, Italy) and the
resulting cell suspension was counted under a phase-contrast inverted
microscope. The viable cells with intact cell membranes, which were able
to exclude the dye, were counted using a haemocytometer and expressed
as percentage over the total cell counted (cell viability).
Lactate dehydrogenase (LDH) release into the culture medium, a marker
of cell mortality, particularly of necrotic death, was determined by using a
cytotoxicity detection kit (Promega, USA). LDH release was calculated with
respect to the total LDH content measured after complete cell lysis by 1%
Triton-X-100.
Statistical analysis
All values are expressed as mean  S.E.M. Comparisons were performed
using ANOVA followed by a Tukey–Kramer multiple comparison test.
Correlation coefficient r was obtained using a linear (Pearson) correlation
test. Probabilities of P 	 0.05 were considered statistically significant.
Results
Simulated I/R increases intracellular ROS 
production
Cells subjected to simulated I/R showed a significant increase in
intracellular ROS production examined by H2DCF-DA fluorescence
intensity compared with normoxic controls (Fig. 1). To determine
the source of ROS generation, we examined the effects of a flavo-
protein inhibitor DPI and apocynin, both compounds being com-
monly used as NADPH oxidase inhibitors [11], of the mitochondrial
oxidase complex I inhibitor, rotenone, and of the xanthine oxidase
inhibitor, oxypurinol. DPI and apocynin treatment induced a significant
decrease of fluorescence, although apocynin exerted its inhibitory
effect at a higher concentration compared with DPI. Albeit not suf-
ficient to restore completely the conditions of normoxic control
cells, both compounds reduced ROS production to a value similar
to that obtained with the superoxide scavenger Tiron. Rotenone and
oxypurinol had no effect on I/R-induced ROS generation .
Effect of simulated I/R on NADPH oxidase activity
To confirm that simulated I/R-induced ROS production was mainly
attributable to the activation of NADPH oxidase, experiments were
performed in the absence and in the presence of specific oxidase
substrates and superoxide production was measured by lucigenin
chemiluminescence. In the presence of succinate or xanthine,
substrates of the mitochondrial oxidase complex I and of the xan-
thine oxidase, respectively, O2
.
 production was minimal in I/R
cells (Fig. 2A). On the contrary, significantly higher O2
.
 genera-
tion was detected in I/R cells in the presence of NADPH compared
with I/R cells without substrate. The increase of NADPH-dependent
superoxide production was significantly inhibited by DPI and Tiron
J. Cell. Mol. Med. Vol 13, No 8B, 2009
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(Fig. 2B), but was unaffected by rotenone or oxypurinol, support-
ing NADPH oxidase as the likely major source of O2
.
 in cells
exposed to simulated I/R.
Effect of simulated I/R on NOX2 and p47phox
expression
To elucidate the mechanisms underlying NADPH oxidase activation
in cells subjected to simulated I/R, we analysed the expression of
the catalytic subunit NOX2 by Western blot and immunofluores-
cence. As shown in Fig. 3A, immunoblotting of NOX2 membrane
protein expression with a goat polyclonal antibody, widely used by
other authors [28–30], gave two different bands that migrated at
a position of approximately 55–65 kD. These bands presumably
represented unglycosylated NOX2 [31], whereas no band was
detected around 80 kD probably representing glycosylated NOX2.
Notwithstanding the molecular properties of NOX2 detected by the
antibody, it is evident that both bands are more intense in I/R samples
with respect the control, thus suggesting an effective overexpres-
sion of NOX2 protein after I/R. DPI addition had no effect on NOX2
expression. The increase in NOX2 expression was further con-
firmed by immunofluorescence (Fig. 3B). In control H9c2 cells
confocal images showed that NOX2 expression was localized in
plasma membrane and in the cytosol including the perinuclear
region (Fig. 3B-a). After simulated I/R NOX2 labelling appeared
more intense and showed a vesicular or granular pattern in all
these compartments (Fig. 3B-b), that was not modified by DPI
treatment (Fig. 3B-c). To assess whether NADPH oxidase activa-
tion in cells exposed to simulated I/R-matched p47phox overex-
pression and/or translocation, we undertook immunofluorescence
staining. As shown in Fig. 4A, p47phox expression was enhanced
in I/R H9c2 compared with control cells; moreover, the cellular
location of the labelling appeared increased in the cytosol and
especially in the plasma membrane. Treatment with DPI resulted
in a decreased p47phox immunofluorescence staining, which was
mainly evident in the sarcolemma, suggesting a change in p47phox
distribution and supporting the hypothesis of a p47phox transloca-
tion from the cytosol to plasma membrane. To confirm these data,
we analyse p47phox content in the membrane and cytosolic frac-
tions by Western blotting. Figure 4B shows a significantly higher
membrane/cytosolic ratio of p47phox than in controls; DPI treat-
ment abolished this increase (Fig. 4). These results underscore
that, in our experimental conditions, the increase in NADPH 
oxidase activity is due not only to NOX2 overexpression but also
to translocation of the cytosolic subunit p47phox to the membrane.
Lipid peroxidation
Lipid peroxidation resulting from oxidative stress has been impli-
cated in cell death. To test whether simulated I/R-mediated NADPH
Fig. 1 Effects of oxidase inhibitors on intracellular ROS formation in H9c2 cardiac muscle cells exposed to simulated ischaemia followed by reperfu-
sion. DCF fluorescence is expressed as arbitrary units (AU) normalized to cellular protein content. Values are means  S.E.M.; DPI, a flavoprotein
inhibitor; Apocynin (Apo), an NADPH oxidase inhibitor; Rotenone (Rote), a mitochondrial oxidase complex I inhibitor; Oxypurinol (Oxy), a xanthine oxi-
dase inhibitor; Tiron, a superoxide scavenger, used as a control. *P  0.05 and **P  0.01 versus control (normoxic condition); ††P  0.01 versus
I/R; n  6, separate cell cultures.
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oxidase activation was involved in lipoperoxidative cell damage, we
measured MDA cell content as an indirect index of ROS activity in
the absence and in the presence of DPI. Consistent with the differ-
ences observed in ROS production, MDA levels were significantly
increased in cells subjected to simulated I/R. In the presence of
DPI, MDA content was significantly reduced, as we observed with
Tiron treatment (Fig. 5), suggesting that NADPH oxidase-derived
ROS is mainly responsible for oxidative stress damage in I/R cells.
Fig. 2 Superoxide production in ischaemic-
reperfused (I/R) H9c2 homogenate in
response to several substrates (A) and
NADPH-dependent superoxide production
in the absence and in the presence of oxi-
dase inhibitors (B) detected by lucigenin
chemiluminescence. Results are expressed
as MLU per sec. per mg protein. Values are
means  S.E.M.; NADPH, NADPH oxidase
substrate; succinate, mitochondrial oxidase
complex I substrate; xanthine, xanthine oxi-
dase substrate. MLU, mean arbitrary light
units. †P 0.05 and ††P 0.01 versus I/R;
n  6, separate cell cultures.
J. Cell. Mol. Med. Vol 13, No 8B, 2009
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MAPK activation
To elucidate the signal transduction pathway involved in simu-
lated I/R injury, we evaluated the level of phosphorylation of the
three principal members of the MAPK family (p38, ERK and
JNK) by Western blotting. In cells exposed to simulated I/R, no
significant difference were found in the p38 phosphorylation
status (expressed as p-p38/p-38 ratio) with respect to control
cells (Fig. 6A), whereas ERK (p-ERK/ERK ratio) and JNK 
(p-JNK/JNK ratio) phosphorylation were significantly increased
(1.7-fold, P  0.01; and 2-fold, P  0.05; both versus control;
Fig. 6B and C).
In order to verify a possible link of these events with the
NADPH oxidase activation, we analysed ERK and JNK phosphory-
lation in the presence of DPI. DPI treatment decreased significantly
only the p- JNK/JNK ratio; similarly, the selective JNK inhibitor,
Fig. 3 Changes in NOX2 (gp91phox) protein expression in H9c2 cardiac muscle cells subjected to simulated ischaemia and reperfusion in the absence
and in the presence of DPI. (A) Representative immunoblot of NOX2 (upper) and densitometric quantification of NOX2 membrane expression level 
(relative to -actin, used as a loading control) (lower), expressed as fold increase of control. HL-60 cell lysate was used a positive control for the detec-
tion of NOX2. Values are means  S.E.M.; * P  0.05 versus control; n  6, separate cell cultures (B) Confocal images of (a) control, (b) I/R and (c)
DPI-treated I/R H9c2 cells. The cells were fixed and processed as described in Materials and Methods.
2730 © 2008 The Authors
Journal compilation © 2009 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
SP600125, reduced the p- JNK/JNK ratio to control level [32] 
(Fig. 6). In agreement with this effect, a positive correlation 
(r  0.74, P  0.01) was found between NADPH oxidase-derived
superoxide production and JNK activation.
Cell viability and LDH release
As judged by the Trypan blue exclusion assay (Fig. 7A), the viability
of cells submitted to I/R was decreased by 26% with respect to the
controls. Accordingly, the fraction of total LDH released in the cul-
ture medium (Fig. 7B) by I/R cardiomyoblasts was significantly
increased (1.6-fold, P  0.05 versus control). All these effects
were significantly reduced by the treatment with the two unrelated
inhibitors DPI or SP600125; in fact, cell treatment with both
inhibitors resulted in the same protective effect against simulated
I/R-induced cell death. Moreover, the percentage of both viable
cells and released to total LDH showed a significant correlation 
(r  –0.73, P  0.01 and r  0.75, P  0.01, respectively) with
JNK phosphorylation.
Fig. 4 p47phox membrane translocation in H9c2 cardiac muscle cells following simulated ischaemia and reperfusion in the absence and in the presence
of DPI. (A) Immunofluorescence of (a) control, (b) I/R and (c) DPI-treated I/R H9c2 cells. (B) Representative immunoblots of p47phox protein expres-
sion of membrane and cytosolic fraction of H9c2 cardiac muscle cells (upper). Densitometric quantification of the ratio of membrane to cytosolic pro-
tein expression of p47phox (lower). Values are means  S.E.M. **P  0.01 versus control; ††P  0.01 versus I/R; n  6, separate cell cultures.
J. Cell. Mol. Med. Vol 13, No 8B, 2009
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Discussion
The novel finding in this study is that the production of NADPH
oxidase-derived ROS was enhanced in cardiomyoblasts main-
tained for 24 hrs under ischaemia-simulating conditions followed
by 1 hr of simulated ‘reperfusion’. This was accompanied by
increases in lipid peroxidation, in activation of specific redox-
sensitive kinases and cell death. Inhibition of NADPH oxidase
activity by the flavoenzyme inhibitor DPI largely prevented simu-
lated I/R-induced ROS formation; the latter matched a reduction in
MDA content, a significant decrease in p-JNK/JNK ratio and an
evident protection against cell death.
The main aim of our study was to describe the role of NADPH
oxidase in cardiac cell exposed to simulated I/R. In fact, albeit sev-
eral recent studies have examined the influence of myocardial I/R
on NADPH oxidase, there are only few and conflicting data about
the contribution of this oxidase complex to I/R-cell damage and its
regulation. The present investigation follows our previous demon-
stration that, in the myocardium from end-stage ischaemic and
non-ischaemic cardiomyopathy, an increased NADPH oxidase
activity was significantly related with enhanced lipid peroxidation
and activation of redox sensitive kinases. The limitation on finding
a clear evidence for a cause–effect relationship in end-stage hearts
[18] is the reason for using H9c2 cardiomyoblasts line in the pres-
ent study. This cell line, sharing features of adult cardiomyocytes
[24], is considered a valuable model for mechanicistic studies
aimed to investigate the pathways implicated in cardiac cell death
following oxidative stress [33]. Previous works in this area include
studies of oxidative cell damage caused by doxorubicin [33, 34],
hydrogen peroxide [35] and ischaemia/reperfusion [36, 37]. As
indicated in the section ‘Materials and Methods’, we subjected
H9c2 to an in vitro simulated ischaemia for 24 hrs followed by 
1 hr of simulated ‘reperfusion’. In this connection, several reports
have documented the need for long-term hypoxia (24–72 hrs) for
the appearance of evident damages in primary cultures of neonatal
rat cardiac myocytes [37–39], a finding that suggests the pres-
ence of intrinsic mechanisms in cardiac myocytes protecting
these cells from hypoxia-related injury. Unpublished data from our
laboratory confirmed a similar behaviour also for H9c2 cardiomy-
oblasts, indicating 24 hrs of simulated ischaemia followed by 1 hr
of ‘reperfusion’ as the optimal experimental condition to obtain
significant alterations in this cell line.
Potential sources of oxidative stress during I/R include mito-
chondria, NADPH oxidase and xanthine oxidase [6–8, 11].
However, a comprehensive understanding of the relative contribu-
tions of these systems during I/R has not yet emerged. In the
present study, cardiomyoblasts exposed to simulated I/R condi-
tions showed an increased intracellular ROS production that, as
indicated by DCF fluorescence, was remarkably suppressed by the
superoxide scavenger Tiron. A similar significant reduction was
obtained with apocynin, widely considered as a specific NADPH
oxidase inhibitor, and DPI, a potent flavoprotein inhibitor 
non-specific for NADPH oxidase but commonly used as a NOX
inhibitor [11]. On the other hand, rotenone, a specific mitochon-
drial oxidase inhibitor and oxypurinol, a xanthine oxidase inhibitor,
appeared to fail in reducing ROS production. These findings sug-
gest that, under our simulated I/R conditions, superoxide was the
main ROS produced and NADPH oxidase was its major source,
although other contribution in ROS generation cannot be ruled
out. The prominent role of NADPH oxidase in superoxide genera-
tion was confirmed by lucigenin chemiluminescent measurements
showing that NADPH, but not other added substrates, increased
the capacity of cardiomyoblasts exposed to simulated I/R to 
produce such free radical.
Previous investigations in cell and animal models highlighted
that NADPH oxidase activation occurs through either increased
expression or post-translational modifications and translocation
of the oxidase subunits [8, 15, 17, 40]. Recent studies have
reported in H9c2 cell line the presence of the NOX2 (gp91phox) iso-
form previously identified in human cardiomyocytes [41]. We con-
firmed this finding and, in addition, we found that the same cells
subjected to simulated I/R showed an increased expression of
NOX2 (gp91phox); this effect occurred in parallel with an apparent
translocation of p47phox from the cytosol to the membrane, as
shown by a significant increase of the p47phox membrane/cytosol
ratio. Serine phosphorylation of p47phox by protein kinase C (PKC)
appears to be the prerequisite for p47phox translocation and stable
interaction with membrane-bound cytochrome b558 resulting in
oxidase activation [40]. It is well known that many stimuli, such as
angiotensin II or TNF-, can increase NADPH oxidase activity by
PKC activation [40, 42]. PKCs are also important for stress
responses in various tissues and PKC is the primary PKC isoform
that is affected by hypoxia or ischaemia in heart muscle [43, 44].
Recently, some authors have shown that the addition of chelery-
thrine, a broad spectrum PKC inhibitor, or apocynin, a NADPH
Fig. 5 Lipid peroxidation, assessed as intracellular MDA content, in H9c2
cardiac muscle cells subjected to simulated ischaemia followed by reper-
fusion in the absence and in the presence of DPI . Values are expressed
as fold increase of control. *P  0.05 versus control; †P  0.05 versus
I/R; n  6, separate cell cultures.
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oxidase inhibitor, before reoxygenation of anoxic endothelial cells,
decreased O2
.
 production to comparable levels, indicating that
NADPH oxidase activation is PKC-dependent [45]. It seems rea-
sonable that also in our experimental model the activation of PKC
induces p47phox phosphorylation, its subsequent translocation to
the membrane and interaction with membrane-bound cytochrome
b558 followed by the increased production of oxidant species.
Recent studies reported that ischaemia resulted in NOX2 up-
regulation in H9c2 cells and that DPI had no effect on NOX2
expression [41]. In line with this finding, we found that DPI treat-
ment did not decrease NOX2 expression in our cells exposed to
simulated I/R, rather it reduced O2
.
 generation and p47phox
translocation. Although it is generally accepted that DPI decreases
NADPH oxidase-derived ROS production, a reduced p47phox
translocation did not appear so obvious. To our knowledge,
whereas it is recognized that the interaction of apocynin with the
oxidase may form a structure that impedes the formation of the
p47phox subunit-cytochrome b558 assembly [46], no data exist
about the mechanism by which DPI might interfere with p47phox
binding to the oxidase complex. Apart from this aspect that needs
further investigation, the above reported findings suggest that
under our experimental conditions both the increase in NOX2
expression and p47phox translocation to the membrane contribute
to the observed NADPH oxidase activation.
The ROS-mediated membrane lipid peroxidation has been pro-
posed as a main chemical modification resulting in cell death [47].
Our cardiomyoblasts subjected to simulated I/R, in fact, displayed
significant increases in lipid peroxidation, as shown by their MDA
levels, and in cell death. Both these events were prevented by DPI
treatment, which indicates, in agreement with previous findings
[48, 49], NADPH oxidase-generated ROS as major contributors to
the I/R-induced lipid peroxidation and the related effects, includ-
ing cell death.
In this connection, although the downstream pathways
through which NADPH oxidase activation could lead to cardiac cell
death remain to be fully elucidated, it has recently been demonstrated
Fig. 6 Effect of DPI (A, B, C) and of SP600125 (C) on MAPKs activation induced by simulated ischaemia and reperfusion in H9c2 cardiac muscle cells.
Representative immunoblots for p-p38 (A), p-ERK (B) and p-JNK (C) (upper) and respective total protein in H9c2 homogenate (lower). Densitometric
quantification of ratio of phosphorylated to total protein of MAPKs expressed as fold activation relative to control. SP600125, selective JNK inhibitor
compound. *P  0.05 and **P  0.01 versus control; †P  0.05 versus I/R; n  6, separate cell cultures.
J. Cell. Mol. Med. Vol 13, No 8B, 2009
2733© 2008 The Authors
Journal compilation © 2009 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
that myocardial I/R activates MAPK subfamilies, including the
‘stress-responsive’ JNK and p38, both involved in cell death, and
ERK, implicated in cell survival signalling [21, 22, 50]. However,
p38 does not appear to be activated in all I/R models and some
authors reported that during ischaemia the increase of p38 activity
is initially rapid but subsequently declines rapidly [51]. In agree-
ment with these observations, we did not find any modification of
the p-p38/p38 ratio under our experimental conditions. Instead,
we observed a significant activation of ERK and, to a higher extent,
of JNK, whose phosphorylation was positively and significantly
correlated with the cell death indexes. DPI treatment of I/R car-
diomyoblasts did not affect p-ERK/ERK ratio, whereas it signifi-
cantly decreased JNK phosphorylation, suggesting a different
mechanism of I/R-induced activation for these two MAPKs. The
Fig. 7 Effect of DPI and of SP600125 on cell
death of H9c2 cardiac muscle cells exposed
to simulated ischaemia and reperfusion. Cell
death was evaluated by Trypan blue dye
exclusion assay (A) and by LDH released into
the culture medium (B). For Trypan blue
assay, results are expressed as percentage of
the viable cells over the total cell counted,
respectively. For LDH release, results are
expressed as percentage of total LDH con-
tent. **P  0.01 versus control; †P  0.05
and ††P  0.01 versus I/R; n  6, separate
cell cultures.
2734 © 2008 The Authors
Journal compilation © 2009 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
DPI effect on JNK activation was similar to that observed with
SP600125, a specific inhibitor of JNK. Interestingly, these two
unrelated inhibitors displayed a similar protective effect also in
preventing I/R cell death. Taken together, these findings suggest
that the NADPH oxidase-derived superoxide production plays a
relevant role in JNK activation, as demonstrated by the positive
and significant correlation between the two events. In turn, JNK
activation appears to be determinant to induce the death of our
cells exposed to simulated I/R. The simultaneous activation of this
kinase and ERK is not surprising and many in vivo and in vitro
studies reported a concomitant activation of these two kinases
after hypoxia/ischaemia and reoxygenation [35, 52–54]. More -
over, when stimuli concomitantly activate multiple MAPKs the
physiological response to stimulus will depend on the time course
and strength of the signal. The balance between MAPK activation
levels may influence cellular fate and turn towards cell death or
life. In our experimental model, the concomitant activation of ERK
and JNK might explain the moderate increase (about 26%) in cell
death observed in our I/R cells. Moreover, the partial reduction of
ERK phosphorylation following DPI treatment suggests that this
process, at least in our experimental conditions, was activated by
other factors in addition to oxidative stress.
I/R-triggered cardiomyocyte death can occur by either apopto-
sis or necrosis [55]. However, it should be considered that the
mode of cell death resulting from I/R injury depends, to some
extent, on the experimental conditions, and that necrosis and
apoptosis represent only the extremes of a continuum of various
modes of cell death. At any rate, we did not assess the relative
incidence of these two forms of cell death, because this issue was
beyond the scope of the present study.
In conclusion, the present study points out the NADPH oxidase
as the critical enzyme that increases I/R-induced oxidant genera-
tion in cardiac cells and, at the same time, provides evidence for
the mechanism of its activation. Furthermore, the inhibition of the
NADPH oxidase by the flavoenzyme inhibitor DPI largely prevents
I/R-induced lipoperoxidative damage and the activation of JNK
pathway, associated to cell death, without affecting the ERK-related
survival response.
We are conscious that this study was performed using both a
non-contractile cell line, which poorly took account of the load fac-
tor, and an in vitro model of simulated ischaemia/reperfusion,
which is devoid of any exogenous neuro-humoural influence. In
spite of these limitations, the marked improvement of cell survival
resulting from NOX inhibition in our experimental conditions
stresses the importance to perform further investigation, includ-
ing in vivo studies to outline cardioprotective strategies against I/R
injury, a condition of great importance in the clinical setting.
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